Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
Details for Australian Patent Application No. 2004215409 (hide)
International Classifications
Event Publications
1 September 2005 PCT application entered the National Phase
PCT publication WO2004/076411 Priority application(s): WO2004/076411
20 November 2008 Application Accepted
Published as AU-B-2004215409
19 March 2009 Standard Patent Sealed
21 January 2010 Amendment Made
The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.
15 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004215412-Water soluble film for trigger spray bottle solution
2004215407-Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser